Ligand validation:8AWV

GLC: alpha-D-glucopyranose

GLC is a Ligand Of Interest in 8AWV designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8AWV_GLC_A_401	15%	70%	0.192	0.753	0.44	0.72	-	-	1	0	100%	0.7
4ZB5_GLC_A_403	94%	30%	0.083	0.981	1	1.77	1	4	0	0	100%	1
4ZB2_GLC_A_403	89%	34%	0.096	0.976	1.19	1.39	2	2	0	0	100%	1
5ZYE_GLC_A_403	85%	15%	0.079	0.943	1.5	2.24	2	11	1	0	100%	1
4ZBC_GLC_A_407	74%	14%	0.116	0.946	1.03	2.77	1	6	0	0	100%	1
4ZB0_GLC_A_406	67%	19%	0.142	0.951	1.13	2.3	1	8	0	0	100%	1
5O59_GLC_A_608	100%	61%	0.025	0.992	0.81	0.69	-	-	0	0	92%	0.9167
8R4G_GLC_C_1001	100%	39%	0.042	0.991	0.8	1.57	1	3	1	0	100%	1
3W7S_GLC_A_1002	99%	64%	0.046	0.974	0.56	0.83	-	-	0	0	100%	1
5MTT_GLC_A_407	98%	66%	0.053	0.993	0.38	0.92	-	-	0	0	92%	0.5867
2WYN_GLC_C_1548	98%	56%	0.059	0.979	0.65	1.02	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.